Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.7%
5Y CAGR+9.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+9.7%/yr
vs +16.7%/yr prior
5Y CAGR
+9.0%/yr
Consistent
Acceleration
-7.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $92.45M | +17.5% |
| 2024 | $78.65M | +49.0% |
| 2023 | $52.79M | -24.7% |
| 2022 | $70.06M | +49.7% |
| 2021 | $46.79M | -22.0% |
| 2020 | $60.01M | +43.3% |
| 2019 | $41.88M | +11.0% |
| 2018 | $37.73M | +31.7% |
| 2017 | $28.65M | +7.6% |
| 2016 | $26.62M | - |